Inicio > Anatomía Patológica > Resultados histopatológicos en mujeres sometidas a histerectomía con diagnóstico de miomatosis uterina por clínica y ultrasonido transvaginal > Página 6

Resultados histopatológicos en mujeres sometidas a histerectomía con diagnóstico de miomatosis uterina por clínica y ultrasonido transvaginal

FIGURA 11

miomatosis-uterina-otros-diagnosticos
Miomatosis uterina. Otros diagnósticos

Citas y referencias bibliográficas

  1. Kozak LJ, Owings MF, Hall MJ. National Hospital Dis­charge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2005(158):1-199.
  2. Laughlin SK, Schroeder JC, Baird DD: New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010, 28(3):204-17, Epub 2010 Apr22.
  3. Parker WH: Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007, 87(4):725-36, Review.
  4. Smith Sk. The regulation of fibroid growth: Time for a rething Br. J. ObstetGynaecol 1993; 100: 977-8.
  5. Fields KR, Neinstein LS: Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol 1996, 9(4):195-198.
  6. Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94(4):435-438.
  7. Edozien LC. Hysterectomy for benign conditions. BMJ 2005;330(7506):1457-8.
  8. Wegienka G, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obsted Gynecol 2003;101:431-437.
  9. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril 2001; 76:350–7.
  10. Hurley V. Imaging techniques for fibroid detection. Baillières Clin ObstetGynaecol 1998;12:213-24.
  11. Lumsden MA, Wallace EM. Clinical presentation of uterine fibroids. Baillières Clin Obstet Gynaecol 1998;12:177-95.
  12. Parker WH: Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007, 87(4):725-36.
  13. Rein MS, Barbieri RL, Friedman AJ: Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995, 172(1 Pt1):14-18.
  14. Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94(4):435-438.
  15. Jacobson GF, Shaber RE, Armstrong MA, Hung YY. Hysterectomy rates for benign indications. Obstet Gy­necol 2006;107(6):1278-83.
  16. Carlos Fernández del Castillo-Sánchez et al. Inconformidades por miomatosis uterina ante Conamed Rev Med Inst Mex Seguro Soc 2007; 45 (6): 629-638.
  17. Canales Eduardo, Correlación del diagnóstico clínico ultrasonográfico y anatomopatológico de la miomatisis uterina Hospital Carlos Robertos Huembes: enero 1993-diciembre 1994.
  18. Wilson Mejía Mejía y Col.Correlacion entre el diagnóstico clínico e histopatológico en una población de mujeres histerectomizadas en el Hospital Maternidad Nuestra Señora de la Altagracia, Santo Domingo, República Dominicana durante el periodo enero-diciembre 2000.
  19. Kawaguchi K, Fujii S, Konishi I. Mitotic activity in uterine leimyomas during the menstrual cycle. Am J Obstet Gynecol 1989; 160: 637-641.
  20. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL,Rosenberg L. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005 May;16:346-354.
  21. Huyck KL, Panhuysen CIM, Cuenco KT, et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol 2008;198:168.e1-168.e9.
  22. Lefebvre G, Allaire C, Jeffrey J, et al. SOGC clinical guidelines. Hysterectomy. J Obstet Gynaecol Can 2002;24(1):37-61.
  23. Osmán Sorto-Murilío, Perfil epidemiológico de la miomatosis uterina, Diagnóstico y tratamiento. Rev Med Post UNAH Vol. 5 No 3 Sept -Dic., 2000.
  24. Cramer SF, Patel A. The frequency of uterine leiomyo­mas. Am J Clin Pathol 1990;94(4):435-8.
  25. Anne Zimmermann, Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women??s Health 2012, 12:6
  26. Wallach E. Vlahos N. Uterine Myomas: An Overview of Development, Clinical Features, and Management. Obste Gynecol 2004;104:393-40.
  27. Guerra de la Garza y Col. Título: Valor diagnóstico del ultrasonido en miomatosis uterina. Ginecol. Obstet. Mex. 59(9):279-82, sept. 1991
  28. Urrea Rivas Marisol y Col. Análisis de la certeza clínica en el diagnóstico de miomatosis uterina. 2005-2006.
  29. Sobande AA, Eskandar M, Archibong EI, Damole IO. Elective hysterectomy: a clinicopathological review from Abha catchment area of Saudi Arabia. West Afr J Med 2005;24(1):31-5.
  30. Pellerin GP, Finan MA. Endometrial cancer in wo­men 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol 2005;193(5):1640-4.
  31. Mortara Gomez AS y col. Sarcoma uterino. Reporte de caso, Ginecol Obstet Mex 2012;80(2):224-227.
  32. http://www.niehs.nih.gov/
  33. Murase Eiko, MD. Uterine Leiomyomas: histopathologic features, MR imaging findings, Differential Diagnosis, and treatment. Scientific Exhibit,. 1999:19 (5): 1179-1197.
  34. Sait K, Alkhattabi M, Boker A, Alhashemi J. Hysterec­tomy for benign conditions in a university hospital in Saudi Arabia. Ann Saudi Med 2008;28(4):282-6.
  35. Carol A. Hulka. Sonographic Findings in Patients with Adenomyosis: Can Sonography Assist in Predicting Extent of Disease?. AJR 2002;179:379–383
  36. Lieng M, Hysteroscopic resection of sympto­matic and asymptomatic endometrial polyps. J Minim Invasive Gynecol 2007;14(2):189-94.
  37. Leal B. Irene, Sensibilidad y especificidad de pruebas diagnósticas para CaCu: muestras de mestizas y tarahumaras del Hospital General Salvador Zubirán de la ciudad de Chihuahua. TecnocienciaChihuahua. 2010; 4(2):97-105.